Skip to content
DataLookout
Menu

CURE-ARCINCT07689435

Cholesterol Cream vs Urea Cream for Skin Barrier and Quality of Life in Ichthyosis

StatusEnrolling by Invitation
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Enrolling by invitation only
    • Eligibility criteria expanded, about 11 words
    • Secondary endpoints: details revised at 5 of 7 entries
    • Site contact updated
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Change in Transepidermal Water Loss (TEWL)
Timeframe: Baseline (Week 0), Week 1, Week 2, and Week 4
Change in Skin Hydration
Timeframe: Baseline (Week 0), Week 1, Week 2, and Week 4

Secondary (7)

Change in Clinical Dryness and Pruritus Score
Change in Investigator's Global Assessment (IGA) Score
Change in Skin Surface pH
Change in Dermatology Life Quality Index (DLQI) Score
Change in Children's Dermatology Life Quality Index (CDLQI) Score
Show 2 moreShow less
Mean Satisfaction Score With 10% Cholesterol Cream and 10% Urea Cream Assessed by Likert Scale Questionnaire
Number of Participants With Clinical Improvement on Standardized Photography as Assessed by Blinded Investigator Review

Arms and interventions

Cholesterol Cream SideExperimental

The body area randomized to receive topical 10% cholesterol cream, applied twice daily to a designated skin site for the duration of the treatment period. This arm represents one side of the within-participant, split-body comparison, in which each participant simultaneously receives 10% cholesterol cream on one body area and 10% urea cream on the contralateral, anatomically matched area. Outcomes assessed on this side include transepidermal water loss (TEWL), skin hydration, skin surface pH, clinical dryness and pruritus severity, and standardized clinical photography.

Urea Cream SideActive comparator

The contralateral, anatomically matched body area randomized to receive topical 10% urea cream, applied twice daily for the duration of the treatment period, serving as the active comparator. This arm represents the other side of the within-participant, split-body comparison, in which each participant simultaneously receives 10% urea cream on this body area and 10% cholesterol cream on the corresponding area on the opposite side. Outcomes assessed on this side include transepidermal water loss (TEWL), skin hydration, skin surface pH, clinical dryness and pruritus severity, and standardized clinical photography, allowing direct within-participant comparison against the cholesterol cream side.

Drugs: 10% Cholesterol Cream, 10% Urea cream

Sites

1 site in 1 country

  • Institute of dermatologyBangkok, Bangkok, Thailand